These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27783972)

  • 1. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein.
    Li S; Zhang W; Yang Y; Ma T; Guo J; Wang S; Yu W; Kong L
    Eur J Med Chem; 2016 Nov; 124():1006-1018. PubMed ID: 27783972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
    Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
    Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonizing STAT3 activation with benzo[b]thiophene 1, 1-dioxide based small molecules.
    Zhang W; Ma T; Li S; Yang Y; Guo J; Yu W; Kong L
    Eur J Med Chem; 2017 Jan; 125():538-550. PubMed ID: 27718470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors.
    Gao D; Jin N; Fu Y; Zhu Y; Wang Y; Wang T; Chen Y; Zhang M; Xiao Q; Huang M; Li Y
    Eur J Med Chem; 2021 Apr; 216():113333. PubMed ID: 33689932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors.
    Cai G; Yu W; Song D; Zhang W; Guo J; Zhu J; Ren Y; Kong L
    Eur J Med Chem; 2019 Jul; 174():236-251. PubMed ID: 31048139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Resveratrol Analogue Promotes ERKMAPK-Dependent Stat3 Serine and Tyrosine Phosphorylation Alterations and Antitumor Effects In Vitro against Human Tumor Cells.
    Chelsky ZL; Yue P; Kondratyuk TP; Paladino D; Pezzuto JM; Cushman M; Turkson J
    Mol Pharmacol; 2015 Sep; 88(3):524-33. PubMed ID: 26138072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.
    Qiu HY; Zhu X; Luo YL; Lin HY; Tang CY; Qi JL; Pang YJ; Yang RW; Lu GH; Wang XM; Yang YH
    Sci Rep; 2017 Jun; 7(1):2863. PubMed ID: 28588262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
    Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z
    Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells.
    Zhong LX; Li H; Wu ML; Liu XY; Zhong MJ; Chen XY; Liu J; Zhang Y
    J Ovarian Res; 2015 Apr; 8():25. PubMed ID: 25896424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701.
    Nishisaka F; Taniguchi K; Tsugane M; Hirata G; Takagi A; Asakawa N; Kurita A; Takahashi H; Ogo N; Shishido Y; Asai A
    Cancer Sci; 2020 May; 111(5):1774-1784. PubMed ID: 32112605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Novel Quinoxaline-Isoselenourea Targeting the STAT3 Pathway as a Potential Melanoma Therapeutic.
    Alcolea V; Karelia DN; Pandey MK; Plano D; Singh P; Palop JA; Amin S; Sanmartín C; Sharma AK
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking.
    Yu W; Li C; Zhang W; Xia Y; Li S; Lin JY; Yu K; Liu M; Yang L; Luo J; Chen Y; Sun H; Kong L
    J Med Chem; 2017 Apr; 60(7):2718-2731. PubMed ID: 28245116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.
    Ashizawa T; Miyata H; Ishii H; Oshita C; Matsuno K; Masuda Y; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Akiyama Y
    Int J Oncol; 2011 May; 38(5):1245-52. PubMed ID: 21369699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting colon cancer with the novel STAT3 inhibitor bruceantinol.
    Wei N; Li J; Fang C; Chang J; Xirou V; Syrigos NK; Marks BJ; Chu E; Schmitz JC
    Oncogene; 2019 Mar; 38(10):1676-1687. PubMed ID: 30348989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells.
    Suzuki Y; Ito S; Sasaki R; Asahi M; Ishida Y
    Leuk Res; 2013 Dec; 37(12):1674-9. PubMed ID: 24090995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.
    Huang W; Dong Z; Chen Y; Wang F; Wang CJ; Peng H; He Y; Hangoc G; Pollok K; Sandusky G; Fu XY; Broxmeyer HE; Zhang ZY; Liu JY; Zhang JT
    Oncogene; 2016 Feb; 35(6):783-92. PubMed ID: 26073084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.
    Kim JE; Kim HS; Shin YJ; Lee CS; Won C; Lee SA; Lee JW; Kim Y; Kang JS; Ye SK; Chung MH
    Exp Mol Med; 2008 Oct; 40(5):514-22. PubMed ID: 18985009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor.
    Cheng X; Liu YQ; Wang GZ; Yang LN; Lu YZ; Li XC; Zhou B; Qu LW; Wang XL; Cheng YX; Liu J; Tao SC; Zhou GB
    Oncotarget; 2017 Jan; 8(2):2681-2693. PubMed ID: 27835873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells.
    Yu LJ; Wu ML; Li H; Chen XY; Wang Q; Sun Y; Kong QY; Liu J
    Neoplasia; 2008 Jul; 10(7):736-44. PubMed ID: 18592012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.